Arbutus Biopharma Corporation (ABUS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$4.34
Day's range
$4.8

Arbutus Biopharma Corp Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
MORGAN STANLEY 05/15/2026 25.89 M $116.51 M   -3.04% 13.51%
TWO SEAS CAPITAL LP 05/15/2026 18.56 M $83.51 M   47.41% 9.69%
WHITEFORT CAPITAL MANAGEMENT, LP 05/15/2026 14.93 M $67.19 M   11.90% 7.79%
BLACKROCK, INC. 05/13/2026 12.97 M $58.35 M   -0.66% 6.77%
05/15/2026 6.69 M $30.10 M   100.00% 3.49%
RUBRIC CAPITAL MANAGEMENT LP 05/15/2026 6.63 M $29.82 M   320.62% 3.46%
STATE STREET CORP 05/15/2026 6.34 M $28.54 M   7.35% 3.31%
BARCLAYS PLC 05/15/2026 4.32 M $19.42 M   1,110.06% 2.25%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 3.77 M $16.98 M   2.57% 1.97%
ADAR1 CAPITAL MANAGEMENT, LLC 05/18/2026 3.13 M $14.10 M   -42.14% 1.64%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2026 2.66 M $11.99 M   -38.60% 1.39%
BLACKBARN CAPITAL PARTNERS LP 05/15/2026 2.50 M $11.25 M   35.14% 1.30%
LEGAL & GENERAL GROUP PLC 05/08/2026 2.40 M $10.81 M   1,856.15% 1.25%
WOODLINE PARTNERS LP 05/15/2026 2.01 M $9.05 M   -8.07% 1.05%
JEFFERIES FINANCIAL GROUP INC. 05/08/2026 1.89 M $8.52 M   100.00% 0.99%
BANK OF AMERICA CORP /DE/ 05/18/2026 1.68 M $7.58 M   -8.13% 0.88%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 1.40 M $6.31 M   -10.31% 0.73%
05/08/2026 1.39 M $6.26 M   100.00% 0.73%
ADVISOR GROUP HOLDINGS, INC. 05/15/2026 1.35 M $6.07 M   -0.01% 0.70%
NORTHERN TRUST CORP 05/14/2026 1.28 M $5.75 M   3.33% 0.67%
GOLDMAN SACHS GROUP INC 05/15/2026 1.10 M $4.95 M   48.99% 0.57%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 1.06 M $4.78 M   100.00% 0.55%
CITIGROUP INC 05/11/2026 898.42 K $4.04 M   47.01% 0.47%
UBS ASSET MANAGEMENT AMERICAS INC 05/13/2026 838.21 K $3.77 M   -5.91% 0.44%
05/15/2026 800.00 K $3.60 M   100.00% 0.42%
BANK OF MONTREAL /CAN/ 05/13/2026 782.76 K $3.52 M   2.10% 0.41%
CITADEL ADVISORS LLC 05/15/2026 677.14 K $3.05 M   545.86% 0.35%
MILLENNIUM MANAGEMENT LLC 05/15/2026 642.45 K $2.89 M   100.00% 0.34%
WESTERN STANDARD LLC 05/05/2026 521.59 K $2.35 M   2.70% 0.27%
QUINN OPPORTUNITY PARTNERS LLC 05/15/2026 514.51 K $2.32 M   0.00% 0.27%
RANGELEY CAPITAL, LLC 05/15/2026 500.00 K $2.25 M   -40.48% 0.26%
FREESTONE CAPITAL HOLDINGS, LLC 05/13/2026 442.50 K $1.99 M   0.00% 0.23%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 440.92 K $1.98 M   -7.05% 0.23%
KENNEDY CAPITAL MANAGEMENT LLC 05/13/2026 393.13 K $1.77 M   -22.17% 0.21%
BANK OF NEW YORK MELLON CORP 05/05/2026 379.37 K $1.71 M   -2.20% 0.20%
UBS GROUP AG 05/05/2026 364.47 K $1.64 M   147.45% 0.19%
HUDSON BAY CAPITAL MANAGEMENT LP 05/13/2026 350.00 K $1.58 M   -48.15% 0.18%
SWISS NATIONAL BANK 05/07/2026 283.40 K $1.28 M   0.00% 0.15%
LEDGEWOOD WEALTH ADVISORS, LLC 04/13/2026 278.44 K $1.25 M   0.00% 0.15%
NUVEEN, LLC 04/30/2026 259.02 K $1.17 M   0.42% 0.14%
CARRERA CAPITAL ADVISORS 05/04/2026 252.16 K $1.13 M   100.00% 0.13%
INVESCO LTD. 05/12/2026 247.93 K $1.12 M   0.27% 0.13%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 241.97 K $1.09 M   121.16% 0.13%
CITIGROUP INC 05/11/2026 230.00 K $1.04 M   -62.90% 0.12%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 211.20 K $950.40 K   9.89% 0.11%
CITIGROUP INC 05/11/2026 200.00 K $900.00 K   -41.04% 0.10%
RAYMOND JAMES FINANCIAL INC 05/14/2026 191.36 K $861.10 K   217.94% 0.10%
RHUMBLINE ADVISERS 05/12/2026 178.79 K $804.53 K   -2.44% 0.09%
DEUTSCHE BANK AG\ 05/06/2026 160.74 K $723.33 K   14.65% 0.08%
FMR LLC 05/15/2026 145.13 K $653.07 K   6.28% 0.08%

Arbutus Biopharma Corp institutional Ownership - FAQ's

During the previous two years, 229 institutional investors and hedge funds held shares of Arbutus Biopharma Corp. The most heavily invested institutionals were:

MORGAN STANLEY: 25.89 M

Two Seas Capital LP: 18.56 M

Whitefort Capital Management, LP: 14.93 M

BlackRock, Inc.: 12.97 M

Rubric Capital Management LP: 6.63 M

STATE STREET CORP: 6.34 M

72.54% of Arbutus Biopharma Corp stock is owned by institutional investors.

Institutional investors have bought a total of 154.57 M shares in the last 24 months. This purchase volume represents approximately $729.58 M in transactions.